Erschienen in:
05.05.2023 | Correspondence
Chat generative pre-trained transformer (ChatGPT): potential implications for rheumatology practice
verfasst von:
Arvind Nune, Karthikeyan. P. Iyengar, Ciro Manzo, Bhupen Barman, Rajesh Botchu
Erschienen in:
Rheumatology International
|
Ausgabe 7/2023
Einloggen, um Zugang zu erhalten
Excerpt
Chat Generative Pre-Trained Transformer (ChatGPT), an artificial intelligence (AI) tool developed by Open AI based on Natural Language Processing models (NLP) has the ability to respond to human prompts following the acquisition of data, information analysis and application of Machine Learning (ML) algorithms. Since its launch in November 2022, ChatGPT-3 has piqued global interest in the medical community regarding how it could revolutionise healthcare delivery [
1]. An enhanced version of ChatGPT-4 based on more than a trillion parameters is claimed to perform better and faster in researching and generating content to support medical research and develop academic content. Current ChatGPT applications include its role in accurate performance at the United States Medical Licencing Exam (USMLE) [
2], writing rheumatology case reports [
3], and generating patient discharge summaries [
4]. …